Skip to main content
Print Save

TEVA 5348 (Methylphenidate Hydrochloride Extended-Release (LA) 40 mg)

Pill with imprint TEVA 5348 is Brown, Capsule-shape and has been identified as Methylphenidate Hydrochloride Extended-Release (LA) 40 mg. It is supplied by Teva Pharmaceuticals USA Inc.

Methylphenidate is used in the treatment of adhd; narcolepsy; depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 40 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for TEVA 5348

Methylphenidate hydrochloride extended-release (LA) 40 mg TEVA 5348

Methylphenidate Hydrochloride Extended-Release (LA)

Imprint
TEVA 5348
Strength
40 mg
Color
Brown
Shape
Capsule-shape
Availability
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC)
00093-5348
Inactive Ingredients
ammonio methacrylate copolymer type B, ferrosoferric oxide, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, hypromellose 2208 (3 mPa.s), methacrylic acid - methyl methacrylate copolymer (1:1), polyethylene glycol 6000, propylene glycol, shellac, corn starch, sucrose, magnesium silicate, titanium dioxide, triethyl citrate, FD&C Yellow No. 6

Note: Inactive ingredients may vary.

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Related images for "TEVA 5348"

Pill TEVA 5343 White Elliptical/Oval is Sildenafil Citrate
Sildenafil Citrate

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer